Investors
Consequence management for regulated AI operations.
OBEXGATE sits between AI systems and the actions they are about to take, enforcing policy, law, authority, and evidence requirements before risk propagates.
Why now
AI adoption created the exposure. Regulation created the urgency.
Organisations are moving AI from experimentation into workflows that affect customers, patients, employees, regulated data, financial decisions, public services, and institutional accountability.
Existing governance stacks typically document policy, monitor outputs, or reconstruct failures after the fact. That approach is too late for regulated operations. By the time a monitoring tool reports an anomaly, the AI-assisted action has often already become operational reality.
The missing layer is execution control: the ability to determine whether an AI-assisted action can proceed, must be held, requires evidence, needs human review, or must be blocked before it propagates.
Regulated organisations deploying AI need auditable proof of pre-action enforcement, not after-the-fact reporting.
Execution control
Governance has to move into the execution path.
OBEXGATE evaluates AI-mediated actions at the point where outputs become decisions, recommendations, workflow steps, external communications, data transfers, classifications, or operational state changes.
→ Allow
The action is within policy, authority, and evidence parameters. It proceeds with a trust receipt.
→ Warn
The action is borderline. It proceeds with an escalation flag and evidence record.
→ Hold
The action requires human review before it can proceed.
→ Block or stop
The action is outside policy, authority, or enforcement tolerance. It is stopped, logged, and evidenced.
Each outcome generates an evidence record: what was proposed, which rule applied, who had authority, what context existed, and what determination was made.
Market entry
Healthcare is the wedge. The primitive is horizontal.
Healthcare creates immediate consequence pressure because AI systems are already entering claims, referrals, prior authorisation, patient communication, clinical documentation, population analysis, payer operations, provider workflows, and secondary data-use environments.
The underlying need is not healthcare-specific. Any regulated sector using AI needs to prove who had authority, what rule applied, what action was proposed, what evidence existed, and why the action was allowed, held, escalated, or blocked.
OBEXGATE is designed for healthcare first because the evidence requirements are high and the consequences of failure are immediate. The same enforcement primitive extends to financial services, public-sector AI, HR and employment decisions, education, and sovereign data environments.
Investor fit
Why this is investable now.
OBEXGATE sits at the intersection of several active venture theses across EU, UK, ANZ, and adjacent regulated markets.
- AI governance moving from policy documentation to execution control
- Regulated vertical AI adoption in healthcare, financial services, and public sector workflows
- AI compliance infrastructure as a horizontal primitive
- Healthcare AI operational risk and evidence requirements
- Sovereign and institutional data authority
- Enterprise evidence, audit readiness, and regulatory proof
- Runtime control and trust for AI agents
Evidence-backed infrastructure
Evidence-backed infrastructure.
OBEXGATE is a live, deployed execution-control platform for regulated AI systems.
Its architecture is built to identify decision boundaries, map governance obligations, evaluate enforcement conditions, and preserve evidence that can support audit, diligence, procurement, and regulatory review.
Detailed architecture, technical proof, and evidence materials are available in the investor diligence pack under NDA.
Claim-status rubrics are kept internal to the diligence pack and content QA process.
Target raise: $750k-$1.5M USD.
OBEXGATE is raising to move from deployed product into pilot-backed execution-control infrastructure for regulated AI systems.
The round is focused on EU, UK, and ANZ deployment pathways. The US is excluded from this round.
Capital will fund product hardening, infrastructure, pilot delivery, regulatory evidence mapping, go-to-market partnerships, marketing, legal/IP protection, privacy and security review, and the core execution runway required to convert pilots into commercial traction.
Use of funds
Capital allocation.
| Use of funds | Allocation |
|---|---|
| Product, engineering, infrastructure, and security hardening | 32% |
| Founder/core team execution runway | 20% |
| Go-to-market, partnerships, and marketing | 18% |
| Regulatory mapping and evidence library | 12% |
| Pilot delivery and implementation support | 10% |
| Legal, IP, privacy, security, and reserve | 8% |
Operating note. Founder and core team execution runway is included across product, pilot delivery, partner development, regulatory mapping, and commercial execution.
The purpose of this capital is to increase execution capacity as OBEXGATE moves from deployed product into pilot-backed commercial infrastructure.
Funding milestones
What each raise level unlocks.
| Raise amount | Milestone |
|---|---|
| $250k-$500k | Complete legal/product hardening, launch self-service EVF, support initial pilots, and validate early paid demand. |
| $750k-$1M | Expand pilot delivery, build the regulatory evidence library, strengthen infrastructure, and develop partner-led go-to-market channels. |
| $1.5M | Convert pilots into repeatable execution-control infrastructure across EU, UK, and ANZ markets. |
Investor materials
OBEXGATE maintains a structured investor diligence pack for qualified investors.
The pack includes product architecture, pilot context, regulatory mapping, evidence framework, technical documentation, raise structure, category framing, and commercial roadmap materials.
Detailed proof materials are shared under NDA where appropriate.